These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25633186)

  • 21. Characteristics of Lipoprotein(a)-Containing Circulating Immune Complexes as Markers of Coronary Heart Disease.
    Klesareva EA; Afanas'eva OI; Donskikh VV; Adamova IY; Pokrovskii SN
    Bull Exp Biol Med; 2016 Dec; 162(2):231-236. PubMed ID: 27905032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating Lp(a):LDL complexes contain LDL molecules proportionate to Lp(a) size and bind to galectin-1: a possible route for LDL entry into cells.
    Kalaivani V; Appukuttan PS
    Lipids; 2014 Nov; 49(11):1101-13. PubMed ID: 25142165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein[a] is the major apoB-containing lipoprotein in the plasma of a hibernator, the hedgehog (Erinaceus europaeus).
    Laplaud PM; Beaubatie L; Rall SC; Luc G; Saboureau M
    J Lipid Res; 1988 Sep; 29(9):1157-70. PubMed ID: 2972788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.
    Bossola M; Tazza L; Luciani G; Tortorelli A; Tsimikas S
    J Nephrol; 2011; 24(5):581-8. PubMed ID: 21404224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial characterization of lipoproteins containing apo[a] in human atherosclerotic lesions.
    Hoff HF; O'Neil J; Yashiro A
    J Lipid Res; 1993 May; 34(5):789-98. PubMed ID: 8509717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A selective bi-site immunoenzymatic procedure for human Lp[a] lipoprotein quantification using monoclonal antibodies against apo[a] and apoB.
    Vu Dac N; Mezdour H; Parra HJ; Luc G; Luyeye I; Fruchart JC
    J Lipid Res; 1989 Sep; 30(9):1437-43. PubMed ID: 2532239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of lipoprotein(a) by oxidation or desialylation influences its ability to compete with plasminogen for binding to the extracellular matrix.
    Pekelharing HL; Kleinveld HA; Duif PF; Bouma BN; van Rijn HJ
    Blood Coagul Fibrinolysis; 1996 Sep; 7(6):641-9. PubMed ID: 8899154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a).
    Callow MJ; Verstuyft J; Tangirala R; Palinski W; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1639-46. PubMed ID: 7657833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings.
    Jenner JL; Seman LJ; Millar JS; Lamon-Fava S; Welty FK; Dolnikowski GG; Marcovina SM; Lichtenstein AH; Barrett PH; deLuca C; Schaefer EJ
    Metabolism; 2005 Mar; 54(3):361-9. PubMed ID: 15736114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.
    Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E
    Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
    Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
    N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects.
    de Bruin TW; van Barlingen H; van Linde-Sibenius Trip M; van Vuurst de Vries AR; Akveld MJ; Erkelens DW
    J Clin Endocrinol Metab; 1993 Jan; 76(1):121-6. PubMed ID: 8421075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbohydrate composition of circulating multiple-modified low-density lipoprotein.
    Zakiev ER; Sobenin IA; Sukhorukov VN; Myasoedova VA; Ivanova EA; Orekhov AN
    Vasc Health Risk Manag; 2016; 12():379-385. PubMed ID: 27789955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dimyristoylphosphotidylcholine induces conformational changes in apoB that lowers lipoprotein(a).
    Wang YT; von Zychlinski A; McCormick SP
    J Lipid Res; 2009 May; 50(5):846-53. PubMed ID: 19098283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of immunosorbents for apoB-containing lipoproteins apheresis.
    Pokrovsky SN; Sussekov AV; Adamova IY; Afanasieva OI; Benevolenskaya GF; Konovalov GA; Kukharchuk VV
    Artif Organs; 1995 Jun; 19(6):500-5. PubMed ID: 8526788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma.
    Steyrer E; Durovic S; Frank S; Giessauf W; Burger A; Dieplinger H; Zechner R; Kostner GM
    J Clin Invest; 1994 Dec; 94(6):2330-40. PubMed ID: 7989589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
    Rasouli M; Kiasari AM; Mokhberi V
    Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome.
    Noto D; Barbagallo CM; Cascio AL; Cefalù AB; Cavera G; Caldarella R; Marino G; Travali S; Cutaia I; Maringhini S; Notarbartolo A; Averna M
    Kidney Int; 1999 Jun; 55(6):2433-9. PubMed ID: 10354292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein (a) and its immune complexes in dyslipidemic subjects.
    Wang J; Zhang C; Chen D; Liu X; Feng X
    Clin Biochem; 2004 Aug; 37(8):710-3. PubMed ID: 15302617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein(a) binding to other apolipoprotein B containing lipoproteins.
    Trieu VN; McConathy WJ
    Biochemistry; 1990 Jun; 29(25):5919-24. PubMed ID: 2143418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.